Selected Grants
Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies
Clinical TrialPrincipal Investigator · Awarded by Janssen Research & Development, LLC · 2024 - 2030PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of Geographic Atrophy (the PHOENIX Study)
Clinical TrialPrincipal Investigator · Awarded by Belite Bio, Inc. · 2024 - 2028Swept Source (SS-) OCT system for Ex-Vivo Imaging, and specialized human postmortem full tissue sample package preparation
ResearchCo Investigator · Awarded by Janssen Research & Development, LLC · 2024 - 2028A randomized, participant and investigator masked, placebo-controlled, multicenter, proof-of-concept study to assess the safety and efficacy of LNP023 (iptacopan) in patients with early and intermediate age-related macular degeneration
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2023 - 2028Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887(AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degen
Clinical TrialPrincipal Investigator · Awarded by Janssen Research & Development, LLC · 2023 - 2028Self-aligning, motion-stabilized ocular imaging for eye care in urgent and emergent care settings
ResearchCo Investigator · Awarded by National Institutes of Health · 2023 - 2027AMD and Validating Rod-Mediated Dark Adaptation with Everyday Task Performance
Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2024 - 2027A Phase 3 open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan in subjects with geographic atrophy secondary to age-related macular degeneration
Clinical TrialPrincipal Investigator · Awarded by Apellis Pharmaceuticals, Inc · 2021 - 2026Predicting early hydroxychloroquine retinopathy using deep learning
ResearchPrincipal Investigator · Awarded by VitreoRetinal Surgery Foundation · 2023 - 2025A Phase 2 Multicenter, Randomized, Double-Masked, Sham-Controlled Study of the Safety and Efficacy of Intravitreal Injections of NGM621 in Subjects with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (CATALINA)
Clinical TrialPrincipal Investigator · Awarded by NGM Biopharmaceuticals, Inc. · 2021 - 2024APL2-304
Clinical TrialPrincipal Investigator · Awarded by Apellis Pharmaceuticals, Inc · 2018 - 2022ARIS: AMD Ryan Initiative Study
ResearchPrincipal Investigator · Awarded by Emmes Corp · 2019 - 2022Lightside III CSP005
Clinical TrialPrincipal Investigator · Awarded by LumiThera, Inc. · 2019 - 2022Pathogenesis of age-related macular degeneration
ResearchCo-Principal Investigator · Awarded by Novartis Pharma AG · 2017 - 2021IPA - Isabelle Doan
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2020 - 2021BIMD - Collaborate Research Agreement
ResearchPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2018 - 2020Monocytes in Dry Age-Related Macular Degeneration
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2019A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF LAMPALIZUMAB IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION WHO HAVE COMPLETED A ROCHE¿SPONSORED STUDY
Clinical TrialPrincipal Investigator · Awarded by F. Hoffmann-La Roche Ltd · 2016 - 2019A Phase II, Multicenter, Randomized, Single-Masked, Sham-Controlled Study of Safety, Tolerability and Evidence of Activity of Intravitreal APL-2 Therapy in Patients Geographic Atrophy (GA) - FILLY
Clinical TrialPrincipal Investigator · Awarded by Apellis Pharmaceuticals, Inc · 2015 - 2019The role of a macrophage chemotactic factor in AMD
ResearchCollaborator · Awarded by BrightFocus Foundation · 2015 - 2017NEI Mentored Clinical Scientist Development Program Award (K12)
ResearchScholar · Awarded by National Institutes of Health · 2004 - 2016Novel Retinal Biomarkers for Early Detection of Alzheimer's Disease
ResearchCo Investigator · Awarded by Alzheimer's Association · 2013 - 2016External Relationships
- 4D Molecular Therapeutics
- Alexion Pharmaceuticals, Inc. a subsidiary of AstraZeneca
- Annexon Biosciences, Inc.
- Apellis Pharmaceuticals
- Aviceda
- Boehringer Ingelheim
- Complement Therapeutics
- Emmecell
- Galimedix
- HealthLadder.AI
- Hoffman LaRoche (Roche Holding)
- Iveric Bio
- Janssen Research & Development
- LABORATOIRES THEA
- LumiThera
- Ocular Therapeutix Inc.
- Osanni Bio
- Regeneron Pharmaceuticals
- Sanofi
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.